F2G inks $100M Series H for another shot at treating fungal infections

Manchester, UK-based F2G has patched together another $100 million in funding a little over a year after receiving a CRL for its experimental fungal infection …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Q&A: BARDA wants to back tech that can combat multiple infections, says director

Share this article BARDA plans to focus on technologies like mRNA, monoclonal antibodies, and nucleic acid therapies, says Dr Robert Johnson. Image Credit: VectorMine /

April 5, 2024

MOSAIC spatial atlas of cancer cells to be created

Owkin, NanoString Technologies and cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander- Universität Erlangen-Nürnberg, and Charité – Universitätsmedizin Berlin are

June 9, 2023

Phylogenomic analysis to generate early warning signs for COVID-19 waves

The Transmission Fitness Polymorphism (TFP) scanner analysis pipeline to detect severe acute respiratory syndrome coronavirus 2.

January 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.